Erika Thompson

Mrs. Erika Thompson


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Papillomavirus Research
Verified
Journal Article
Open access
EDEllen M. Daley
Ellen M. Daley
CVCheryl A. Vamos
Cheryl A. Vamos
ETErika Thompson
Erika Thompson
GZGregory Zimet
Gregory Zimet
ZRZeev Rosberger
Zeev Rosberger
NKNolan S. Kline
Nolan S. Kline
Human papillomavirus (HPV) can cause a number of anogenital cancers (i.e., cervical, penile, anal, vaginal, vulvar) and genital warts. A decade ago, the HPV vaccine was approved, and has been shown to be a public health achievement that can reduce the morbidity and mortality for HPV-associated diseases. Yet, the mistaken over-identification of HPV as a female-specific disease has resulted in the feminization of HPV and HPV vaccines. In this critical review, we trace the evolution of the intersection of science, politics, economics and gender norms during the original HPV vaccine approval, marketing era, and implementation. Given the focus on cervical cancer screening, women were identified as bearing the burden of HPV infection and its related illnesses, and the group responsible for prevention. We also describe the consequences of the feminization of HPV, which has resulted primarily in reduced protection from HPV-related illnesses for males. We propose a multilevel approach to normalizing HPV vaccines as an important aspect of overall health for both genders. This process must engage multiple stakeholders, including providers, parents, patients, professional organizations, public health agencies, policymakers, researchers, and community-based organizations.

11 November 2020 in Public Health Reports®
Verified
Journal Article
Open access
PDF file
SMSarah Maness
Sarah Maness
LMLaura Merrell
Laura Merrell
ETErika Thompson
Erika Thompson
SGStacey B. Griner
Stacey B. Griner
NKNolan Kline
Nolan Kline
CWChristopher Wheldon
Christopher Wheldon

1 June 2017 in Journal of Sport and Health Science
Verified
Journal Article
Open access
ETErika Thompson
Erika Thompson
CVCheryl A. Vamos
Cheryl A. Vamos
EDEllen M. Daley
Ellen M. Daley
Physical activity (PA) during pregnancy provides physical and psychological benefits for mother and child. U.S. guidelines recommend ≥30 min of moderate exercise for healthy pregnant women most days of the week; however, most women do not meet these recommendations. Theory assists in identifying salient determinants of health behavior to guide health promotion interventions; however, the application of theory to examine PA among pregnant women has not been examined cohesively among multiple levels of influence (e.g., intrapersonal, interpersonal, neighborhood/environmental, and organizational/political). Subsequently, this systematic review aims to identify and evaluate the use of health behavior theory in studies that examine PA during pregnancy. Articles published before July 2014 were obtained from PubMed and Web of Science. Inclusion criteria applied were: (1) empirically-based; (2) peer-reviewed; (3) measured factors related to PA; (4) comprised a pregnant sample; and (5) applied theory. Fourteen studies were included. Each study's application of theory and theoretical constructs were evaluated. Various theories were utilized to explain and predict PA during pregnancy; yet, the majority of these studies only focused on intrapersonal level determinants. Five theoretical frameworks were applied across the studies-all but one at the intrapersonal level. Few determinants identified were from the interpersonal, neighborhood/environmental, or organizational/political levels. This systematic review synthesized the literature on theoretical constructs related to PA during pregnancy. Interpersonal, community, and societal levels remain understudied. Future research should employ theory-driven multi-level determinants of PA to reflect the interacting factors influencing PA during this critical period in the life course.

1 March 2020 in Vaccine
Verified
Journal Article
Closed access
ETErika Thompson
Erika Thompson
CWChristopher W. Wheldon
Christopher W. Wheldon
BRBrittany L. Rosen
Brittany L. Rosen
SMSarah Maness
Sarah Maness
MKMonica L. Kasting
Monica L. Kasting
PMPhilip Massey
Philip Massey

1 May 2016 in Preventive Medicine
Verified
Journal Article
Closed access
ETErika Thompson
Erika Thompson
CVCheryl A. Vamos
Cheryl A. Vamos
CVCoralia Vázquez-Otero
Coralia Vázquez-Otero
RLRachel Logan
Rachel Logan
SGStacey Griner
Stacey Griner
EDEllen M. Daley
Ellen M. Daley

1 September 2017 in Journal of Adolescent Health
Verified
Journal Article
Closed access
ETErika Thompson
Erika Thompson
BRBrittany L. Rosen
Brittany L. Rosen
CVCheryl A. Vamos
Cheryl A. Vamos
MKMika Kadono
Mika Kadono
EDEllen M. Daley
Ellen M. Daley